RecruitingGlaucoma
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Eligible age
18+ yrs
Accepts
All genders
Locations
3 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Sponsor: Glaukos Corporation
You may qualify if…
- ✓ Diagnosis of open-angle glaucoma or ocular hypertension in the study eye
You may not qualify if…
- ✕ Prior incisional glaucoma surgery in the study eye
- ✕ Prior argon laser trabeculoplasty (ALT) in the study eye
- ✕ Prior minimally invasive glaucoma (MIGS) surgery in the study eye
Where it's recruiting
Source: ClinicalTrials.gov · NCT07075718 · last updated 2026-03-02